The Global Computational Biology Market is expected to reach USD 4,285.1
million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand
View Research, Inc. Steady increase in the usage & application of
computational biology for bioinformatics R&D programs designed for
sequencing genomes to better understand biological systems and increasing
number of clinical studies in pharmacogenomics and pharmacokinetics for novel
drug discovery studies are expected to drive computational biology demand over
the next six years.
Computational genomics for cellular and biological simulation
applications dominated the market in 2013, accounting for over 47% of global
revenue. Key factors driving demand for these applications include the growth
of drug designing, disease modeling and personalized medicine applications and
the growing usage of computational biology for functional and structural
genomics, epigenomics and metagenomics for the analysis of protein
transcription, protein-protein interactions, gene sequencing and expression and
3-dimensional protein structure analysis.
In depth research report
on Computational Biology Market
Further key findings from
the study suggest:
·
North America was the largest regional market, accounting for 58.0% of
the global revenue in 2013. Its large share is majorly attributed to the
growing research investments and initiatives for development of drug discovery,
disease modeling technologies and innovations in biological computation
methods. It is expected that Asia Pacific will witness the fastest growth in
the market, at an estimated CAGR of 28.0% owing to the increasing expenditure
in clinical studies for pharmacokinetics and pharmacogenomics.
·
The application of computational biology in proteomics for cellular
simulation is expected to grow at the fastest CAGR of over 22% owing to the
shift in sequencing studies towards further analysis of the nature of various
biological proteins as a part of development of personalized medicine.
·
Drug discovery and disease modelling applications dominated the market,
accounting for 58.0% of global revenue in 2013. This large share is attributed
by the extensive drug development pipelines present for a number of global
branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and
Eli Lilly.
·
Computational Biology databases dominated the tools segment and accounted
for 44.5% of the market revenue in 2013, owing to extensive genomic database
usage for warehousing and data mining of biological and sequential data
generated from genomic and proteomic studies. Consequentially, the software and
services for the analysis of biological data is expected to witness the fastest
CAGR of over 21.0%.
·
Key players of this market include Schrodinger, Accelrys, Certara,
Entelos, Simulation Plus and others.
For the purpose of this study, Grand View Research has segmented the
computational biology market on the basis of applications, tools, services, end
users and region:
Computational Biology Application Outlook
·
Cellular & Biological Simulation
o
Computational Genomics
o
Computational Proteomics
o
Pharmacogenomics
o
Others (Transcriptomics/Metabolomics)
·
Drug Discovery and Disease Modelling
o
Target Identification
o
Target Validation
o
Lead Discovery
o
Lead Optimization
·
Preclinical Drug Development
o
Pharmacokinetics
o
Pharmacodynamics
·
Clinical trials
o
Phase I
o
Phase II
o
Phase III
·
Human Body Simulation Software
Computational Biology
Tools Outlook
·
Databases
·
Infrastructure (Hardware)
·
Analysis Software & Services
Computational Biology
Services Outlook
·
In-house
·
Contract
Computational Biology End
User Outlook
·
Academics
·
Industry
·
Commercial
Computational Biology
Regional Outlook
·
North America
·
Europe
·
Asia Pacific
·
RoW
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment